SCHEMBL6505172

SCHEMBL6505172

COC(=O)C(Cc1ccc(O)cc1)C(C)=NOCc1ccc(C)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.47
ESR2 Q92731 2/20 0.47
MIF P14174 2/20 0.44
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PTPRB P23467 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
PPARG P37231 4/20 0.40
PPARA Q07869 4/20 0.40
TSHR P16473 1/20 0.40
LNPEP Q9UIQ6 1/20 0.40
MDM4 O15151 1/20 0.40
MDM2 Q00987 1/20 0.40
S1PR1 P21453 1/20 0.39
PTGS2 P35354 2/20 0.38
NLRP3 Q96P20 1/20 0.37
PPARD Q03181 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6504111 0.90 MIF (0.50) ESR1ESR2MIFATMPPARG
SCHEMBL6504116 0.90 MIF (0.50) ESR1ESR2MIFATMPPARG
SCHEMBL6510664 0.89 ESR1 (0.46) ESR1ESR2MIFPTPRBKMT2A
SCHEMBL6506105 0.89 PPARG (0.46) ESR1ESR2MIFPTPRBKMT2A
SCHEMBL6510040 0.86 ESR1 (0.50) ESR1ESR2MIFPTPRBKMT2A
SCHEMBL6507933 0.86 ESR1 (0.50) ESR1ESR2MIFPTPRBKMT2A
SCHEMBL5798930 0.84 ESR1 (0.54) ESR1ESR2MIFPTPRBKMT2A
SCHEMBL5798926 0.84 ESR1 (0.54) ESR1ESR2MIFPTPRBKMT2A
SCHEMBL6510326 0.84 MIF (0.48) ESR1ESR2MIFPTPRBKMT2A
SCHEMBL6511070 0.84 ESR1 (0.48) ESR1ESR2MIFPTPRBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005040127-A1 NOVEL COMPOUNDS AS AGONIST FOR PPAR GAMMA AND PPAR ALPHA, METHOD FOR PREPARATION OF THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME LG LIFE SCIENCES LTD. (KR) 2005-05-06 WO disclosed